Risk factors for mortality during antiretroviral therapy in older populations in resource-limited settings
暂无分享,去创建一个
N. Ford | T. Spelman | E. Casas | D. O’Brien | C. Ssonko | A. Mesic | J. Greig | J. McMahon | P. D. du Cros
[1] 黄亚明,et al. Journal of the International AIDS Society , 2017 .
[2] L. Myer,et al. Age in antiretroviral therapy programmes in South Africa: a retrospective, multicentre, observational cohort study. , 2015, The lancet. HIV.
[3] W. El-Sadr,et al. Characteristics and Outcomes among Older HIV-Positive Adults Enrolled in HIV Programs in Four Sub-Saharan African Countries , 2014, PloS one.
[4] J. Elliott,et al. Impact of Hiv-Associated Conditions on Mortality in People Commencing Anti-Retroviral Therapy in Resource Limited Settings , 2013, PloS one.
[5] N. Ford,et al. Male sex and the risk of mortality among individuals enrolled in antiretroviral therapy programs in Africa: a systematic review and meta-analysis , 2013, AIDS.
[6] T. Spelman,et al. Incidence of WHO Stage 3 and 4 Conditions following Initiation of Anti-Retroviral Therapy in Resource Limited Settings , 2012, PloS one.
[7] N. Ford,et al. Association between older age and adverse outcomes on antiretroviral therapy: a cohort analysis of programme data from nine countries , 2012, AIDS.
[8] R. Baltussen,et al. The impact of antiretroviral treatment on the age composition of the HIV epidemic in sub-Saharan Africa , 2012, AIDS.
[9] M. Fox,et al. Poorer ART Outcomes with Increasing Age at a Large Public Sector HIV Clinic in Johannesburg, South Africa , 2012, Journal of the International Association of Physicians in AIDS Care.
[10] Thomas Lengauer,et al. Risk Factors Associated with Older Age in Treatment-Naive HIV-Positive Patients , 2012, Intervirology.
[11] E. Mills,et al. Ageing faster with AIDS in Africa , 2011, The Lancet.
[12] Richard D Moore,et al. CD4 count at presentation for HIV care in the United States and Canada: Are those over 50 years more likely to have a delayed presentation? , 2010, AIDS research and therapy.
[13] R. Cumming,et al. HIV infection in older adults in sub-Saharan Africa: extrapolating prevalence from existing data. , 2010, Bulletin of the World Health Organization.
[14] J. Sterne,et al. Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes , 2010, The Lancet.
[15] P. Davies,et al. Tuberculosis at extremes of age , 2010, Respirology.
[16] N. Ford,et al. Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa , 2010, AIDS.
[17] D. Schopper,et al. Research Ethics Review in Humanitarian Contexts: The Experience of the Independent Ethics Review Board of Médecins Sans Frontières , 2009, PLoS medicine.
[18] A. d’Arminio Monforte,et al. Response to combination antiretroviral therapy: variation by age , 2008, AIDS.
[19] L. Sandvik,et al. Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania , 2008, BMC infectious diseases.
[20] L. Palombi,et al. Excessive early mortality in the first year of treatment in HIV type 1-infected patients initiating antiretroviral therapy in resource-limited settings. , 2008, AIDS research and human retroviruses.
[21] Gemma Navarro,et al. Bmc Infectious Diseases Epidemiological and Clinical Features, Response to Haart, and Survival in Hiv-infected Patients Diagnosed at the Age of 50 or More , 2022 .
[22] E. Delaporte,et al. Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study , 2006, AIDS.
[23] D. Costagliola,et al. Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIV , 2004, AIDS.
[24] L. Lynen. Clinical HIV/AIDS care guidelines for resource-poor settings. 2nd ed. , 2006 .